Periodic Reporting for period 1 - InterMet (Intercellular trading in nucleotide metabolism: an emerging target)

Nucleotides are the oldest target in cancer treatment. Despite its long history, therapies that target nucleotide metabolism suffer high rates of resistance and toxicity. What are the reasons? A cell can gain nucleotides via de novo synthesis or from salvage pathways. This...